5849974
Last Update Posted: 2023-05-23
Recruiting has not begun
All Genders accepted | 6 Years + |
1000 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Large Cohort of 1000 Patients With Severe Myopia
The prevalence of myopia and severe myopia are increasing and will affect 50% and 10% of the population respectively. Severe myopia exposes an increased risk of glaucoma, cataract, retinal detachment and myopic maculopathy, a source of visual impairment.
To date, no European cohort study has been conducted to estimate the rate of these complications and to study the predictive parameters.
This study allows to describe the evolution of different ophthalmological parameters of a population of strong myopes during their follow-up for 10 years using multimodal imaging techniques of the retina.
Prospective, longitudinal, multicentric, non-randomized cohort study with constitution of a biological collection.
This study will include major and minor patients with high myopia
Eligibility
Relevant conditions:
Myopia, Severe
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov